Researchers Awarded Grant to Study New Method of Islet Transplantation

January 5, 2022

Members of the Weill Center for Metabolic Health, Dr. Rebecca Craig-SchapiroDr. Shahin Rafii, and Dr. Qiao Zhou, have received a two-year $500,000 grant from JDRF to evaluate an innovative approach to islet cell transplantation, an experimental treatment for difficult-to-control type 1 diabetes. The research will be conducted in mouse models of this disease.

Read more

Faculty Honors and Awards

December 30, 2021

Metabolic Center member Dr. Louis Aronne, the Sanford I. Weill Professor of Metabolic Research and a professor of clinical medicine, has been awarded the Clinician of the Year Award by the Clinical Management of Obesity Section of The Obesity Society. The Clinician of the Year Award signifies excellence in the practice of obesity medicine and distinguishes a physician as having achieved a high level of competency and understanding in obesity care.

Researchers Identify Significant Differences in Tumor Characteristics Between Younger and Older Cancer Patients

December 7, 2021

Investigators led by our Metabolic Center member Dr. Olivier Elemento have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types. Their research, published Dec. 7 in Cell Reports, suggests that cancer treatment could potentially be tailored by age. The study also identified pre-existing drugs that could target mutations predominantly found in younger cancer patients—promising candidates for future clinical research.

Read more

Protein Variant Identified that Renders Chemotherapy Ineffective in Gastric Cancer

December 6, 2021

A new protein variant underlies the ability of gastric cancers to resist an otherwise effective family of chemotherapy drugs, according to a study by a multidisciplinary team including co-senior author Dr. Olivier Elemento, a member of the Weill Center for Metabolic Health. The results suggest a treatment strategy that could improve the prognoses of many patients with cancer.

Read more

Researchers Discover the Role the Gene SATB2 Plays in the Colon Lining

October 28, 2021

Loss of the gene SATB2 contributes to changes in stem cells that typically develop into the inner lining of the colon, or large intestine, transforming them into a cell type that normally lines a portion of the small intestine called the ileum, according to new preclinical research led by our Metabolic Center member, Dr. Joe Zhou, in a study published Sept. 27 in Cell Stem Cell

Read more

Dr. Kristy Brown was just appointed Co-Editor-in Chief of the journal Endocrine and Metabolic Science. This is a broad-scope, open access journal accepting basic, translational and clinical original articles, reviews, clinical trials and case reports on all aspects of endocrinology and metabolism. Dr. Brown looks forward to building this new journal that focusses on many exciting areas of research relevant to our faculty, including obesity and...

COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian. 

In the ...

On September 22, 2021, the Joan and Sanford I. Weill Center for Metabolic Health officially opened with introductory comments by Dr. Laura Alonso, the Center’s Director and Chief of the Division of Endocrinology, Metabolism and Diabetes, Dr. Tony Hollenberg, Chair, Weill Department of Medicine, and Dean Augustine Choi, Dean of Weill Cornell Medicine. Also in attendance were Dr. Lou Aronne, Director of the Comprehensive Weight Control Center, and a vaccinated, masked and socially distanced...

Weill Cornell Medicine
Center for Metabolic Health
413 E 69th St, 6th Floor New York, NY 10021 Phone: (646) 962-6193